Friederike Holze

Psychedelic Research @UniSpitalBasel, Liechti Lab.

[Friederike Holze @deedsou]

🚨 Out today in @TheBJPsych 🚨 Our latest study shows that LSD-assisted therapy can significantly reduce anxiety and depression, with lasting effects up to almost 2 years. Exciting potential of #LSD for #anxiety treatment! 🌟 #Psychdedelics https://t.co/Y6LFrvlXc5

[Lucie Berkovitch @LucieBerkovitch]

🔬🧠International experts such as @KatrinPreller, Guy Goodwin, @DavidErritzoe, Friederike Holze @deedsou, Amandine Luquiens, Lea Mertens @mertens_lj, Christian Lüscher, Mickael Naassila @RechercheAlcool and Matthias Liechti will present the latest news regarding #psychedelics.

[Neuropsychopharmacology @npp_journal]

Check out what's new #ThisWeekInNPP

See below for new insights into mechanisms underpinning clozapine's effects, interactions between methamphetamine & serotonin, and neural signatures of late-life depression ⤵️

[Neuropsychopharmacology @npp_journal]

It's time for another recap of what's new #ThisWeekInNPP

See below for @npp_journal papers on novel treatments for youth cannabis use disorder, interactions between opioid receptor availability & family environment, and factors contributing to postpartum depression ⤵️

[Neuropsychopharmacology @npp_journal]

In honor of Black History Month, we will share NPP resources for Black & URM trainees, re-visit evidence-based NPP articles showing the impacts of systemic racism & highlight Black NPP authors & @ACNPorg members who are improving our communities through research & advocacy 👇

[Friederike Holze @deedsou]

Our latest research describes the treatment of a patient with neuropathic pain who was successfully treated with low-dose #MDMA #psychedelics https://t.co/rkCBdEOEur

[Dr. Briana Chen 陳 家 瑩 @BriKChen]

So excited to welcome @deedsou to the NPP Special Projects team! 🥳

[NPP-Digital Psychiatry and Neuroscience (DPN) @dpn_journal]

Join us in congratulating @npp_journal’s new Editorial Intern, @deedsou 👏👏

[Friederike Holze @deedsou]

Super excited to join the team!!🎉🔥

[Neuropsychopharmacology @npp_journal]

Hey, did you see our big news? We have a new NPP Editorial Intern - the one and only @deedsou

If you see Friede at #ACNP2024 - be sure to say hello to the newest part of our @npp_journal Social Media team

[Friederike Holze @deedsou]

@FredBarrettPhD @JHPsychedelics Congrats, Fred!

[Friederike Holze @deedsou]

Our latest research dives into the potential mechanism of #MDMA induced hyponatremia and identifies #oxytocin as potential key factor. Good news: fluid restriction migitates the risk!

[JAMA Network Open @JAMANetworkOpen]

In this secondary analysis of 4 randomized clinical trials, a high incidence of acute hyponatremia was seen in response to MDMA, which may be mitigated by fluid restriction. https://t.co/3QxhF7gK5a

[Friederike Holze @deedsou]

Honoured to be one of this year's @SwissSsbp Young investigator award recipients! Thank you!

[Sebastian Walther @WaltherSeb]

SSBP annual meeting is going excellent. The General Assembly has just appointed a new executive board. Young investigator awards went to @deedsou and @FlurinCathomas
Poster award to @lijing_MR

[Swiss Society of Biological Psychiatry (SSBP) @SwissSsbp]

Instead of waiting on US presidential election results, consider spending the day with cutting-edge mental health science in Zürich. Tomorrow, Nov 6 from 9:30 onwards at the University Hospital of Psychiatry

[Friederike Holze @deedsou]

@ConnorHaggarty Thank you☺️ maybe that's my fate..

[Friederike Holze @deedsou]

When your paper makes it to the cover but they mix up first and last author 💔

[Neuropsychopharmacology @npp_journal]

We're creeping up to 10,000 followers! 🤩

We hope to make it there ahead of #ACNP2024, so if you don't follow us yet, maybe you'll consider it? 🤔

Of course, we're not above a little bribery 😏

The follower who takes us to 10k will get some fun @ACNPorg & @npp_journal swag 😎

[Friederike Holze @deedsou]

It's today! If you're in Milan and interested in #psychedelics stop by! #ECNP

[Friederike Holze @deedsou]

I'm happy to be part of the 37th ECNP Congress, 21-24 September. Join my poster P1037 on #LSD-assisted theapy in anxiety, at poster session on 22/09/24, 12:35 - 14:00.

Programme: https://t.co/cheWil7xDO

See you in Milan!

#ECNP2024 @ECNPtweets #psychiatry #psychedelics

[Friederike Holze @deedsou]

Congratulations to @PsyMihai and all other co-authors on investigating the shared and distinct connectivity properties of three prototypical psychoactive compounds. Classic #psychedelics seem to go their own way :) !

[Friederike Holze @deedsou]

I'm happy to be part of the 37th ECNP Congress, 21-24 September. Join my poster P1037 on #LSD-assisted theapy in anxiety, at poster session on 22/09/24, 12:35 - 14:00.

Programme: https://t.co/cheWil7xDO

See you in Milan!

#ECNP2024 @ECNPtweets #psychiatry #psychedelics

[Johns Hopkins Psychedelic Research Center @JHPsychedelics]

New paper published in @JAMAPsych: A meta-analysis of adverse events in trials of classic psychedelics suggests an overall favorable safety profile. However, serious adverse events, while rare, did occur. It highlights ways to improve the detection and reporting of adverse events and calls for urgent improvements.

Link: https://t.co/LSOeYYPqwd

Led by Jared Hinkle MD/PhD (@jaredhinkle4), w/ CPCR researchers Marianna Graziosi (@MariannaGrazz), Sandeep Nayak (@sdpnayak), and David Yaden (@ExistWell).

[Friederike Holze @deedsou]

@ee_schenberg @AaronCherniak @p_vizeli Not sure, because it unblinds via the acute experience and what we are looking at here, is the acute experience, or what are you suggesting?

[Friederike Holze @deedsou]

🚨New Paper🚨 We explored pharmacological and extra-pharmacological predictors of the #psychedelic #LSD experience!Dose is key! Personality traits, mood, and pre-drug states are also major influencers! Sex and body weight? Not so much! @p_vizeli https://t.co/8gmjDaq8Ea